Faculty Profile

Tenzin Choden
Section of Gastroenterology
Assistant Professor of Medicine

Academic Interests

Dr. Choden’s primary research interest involves studying various elements in the care of the older patient with inflammatory bowel disease (IBD) such as frailty, medication management, and cancer surveillance.

Clinical Interests

Ulcerative colitis, Crohn’s disease, checkpoint inhibitor colitis


  • Choden T, Yeager M, Cohen RD. Checking Out the Associations Between Inflammatory Bowel Disease and Checkpoint Inhibitor Colitis. Dig Dis Sci. 2022 Nov;67(11):5010-5013.
  • Choden T, Cohen NA, Rubin DT. Sphingosine-1 Phosphate Receptor Modulators: The Next Wave of Oral Therapies in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2022 May;18(5):265-271.
  • Cohen NA, Choi D, Choden T, Cleveland NK, Cohen RD, Rubin DT. Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data from a Large Tertiary Center. Clin Gastroenterol Hepatol. 2022 Apr 2:S1542-3565(22)00310-X.
  • Sundaram S, Choden T, Mattar MC, Desai S, Desai M. Artificial intelligence in inflammatory bowel disease endoscopy: current landscape and the road ahead. Ther Adv Gastrointest Endosc. 2021 Jul 14;14:26317745211017809.
For a complete list of publications click here:


  • BS, 2010, University of Virginia, Biomedical Engineering
  • MS, 2011, Eastern Virginia Medical School, Biomedical Sciences
  • MD, 2015, Eastern Virginia Medical School
  • Residency, 2018, MedStar Georgetown University Hospital, Internal Medicine
  • Fellowship, 2021, MedStar Georgetown University Hospital, Gastroenterology and Hepatology
  • Chief Fellow, 2021, MedStar Georgetown University Hospital, Gastroenterology
  • Fellowship, 2022, University of Chicago Medical Center, Advanced Fellowship in Inflammatory Bowel Disease